Engineering Forward Initiative for Childhood Cancer Therapies: $1,500,000

Be the sponsor for this project!

This multi-disciplinary approach to accelerating discovery of therapies for childhood cancer is made possible by a joint effort of our scientific director Dr. Keller and our two past Intel Vice President Board member.  Together, our teams of biologists and engineers will maximize automation and the design of new devices and biomaterials that address challenges in the treatment of cancer as well as prevention of recurrence, ultimately improving outcomes for children with cancer.  The range of projects will include advanced analytics for new drug therapies, sensing technologies, machine learning for more accurate diagnoses of childhood cancer in the developed and developing world, AI for in silico drug development with the World Community Grid, bio-engineering methods and other ideas that emerge from this cause.